Hypertension Research, ISSN 0916-9636, 04/2017, Volume 40, Issue 4, pp. 305 - 310
Preeclampsia is a systemic vascular disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. This condition targets...
soluble fms-like tyrosine kinase 1 | angiogenic imbalance | preeclampsia | systemic vascular dysfunction | PREGNANCY-INDUCED HYPERTENSION | PULSE-WAVE VELOCITY | DISEASE RISK-FACTORS | SOLUBLE ENDOGLIN | MATERNAL PLASMA-CONCENTRATIONS | TYROSINE KINASE 1 | BLOOD-PRESSURE | ARTERIAL STIFFNESS | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | ENDOTHELIAL GROWTH-FACTOR | Pregnancy | Humans | Endothelium, Vascular - physiopathology | Female | Neovascularization, Pathologic - physiopathology | Pre-Eclampsia - etiology | Pre-Eclampsia - physiopathology | Kidney - physiopathology
soluble fms-like tyrosine kinase 1 | angiogenic imbalance | preeclampsia | systemic vascular dysfunction | PREGNANCY-INDUCED HYPERTENSION | PULSE-WAVE VELOCITY | DISEASE RISK-FACTORS | SOLUBLE ENDOGLIN | MATERNAL PLASMA-CONCENTRATIONS | TYROSINE KINASE 1 | BLOOD-PRESSURE | ARTERIAL STIFFNESS | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | ENDOTHELIAL GROWTH-FACTOR | Pregnancy | Humans | Endothelium, Vascular - physiopathology | Female | Neovascularization, Pathologic - physiopathology | Pre-Eclampsia - etiology | Pre-Eclampsia - physiopathology | Kidney - physiopathology
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 1/2011, Volume 108, Issue 4, pp. 1451 - 1455
Preeclampsia is a relatively common pregnancy-related disorder. Both maternal and fetal lives will be endangered if it proceeds unabated. Recently, the...
Hypertension | Pregnancy | Animal models | Reproduction | Placenta | Fetal growth retardation | Preeclampsia | Blastocyst | Blood pressure | Female animals | Hemolytic anemia, elevated liver enzymes, and low platelet count | Trophoblast | 3-hydroxy-3-methyl-glutaryl-CoA | LOVASTATIN | ANGIOGENESIS | LENTIVIRUS | MULTIDISCIPLINARY SCIENCES | SOLUBLE ENDOGLIN | hemolytic anemia, elevated liver enzymes, and low platelet count | PREGNANCY | GENE-TRANSFER | FETAL | trophoblast | SIMVASTATIN | HYPERTENSION | EXPOSURE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Pre-Eclampsia - genetics | Humans | Pregnancy Proteins - genetics | Male | Pregnancy Proteins - metabolism | Pre-Eclampsia - prevention & control | HEK293 Cells | Female | Lentivirus - genetics | Pre-Eclampsia - metabolism | Disease Models, Animal | Vascular Endothelial Growth Factor Receptor-1 - genetics | Animals, Newborn | Pravastatin - pharmacology | Cell Line | Transduction, Genetic | Injections, Intraperitoneal | Mice, Transgenic | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Placenta - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Pravastatin - administration & dosage | Placenta Growth Factor | Mice | Development and progression | Models | Dosage and administration | Drug therapy | Pravastatin | Vascular endothelial growth factor | Health aspects | Biological Sciences
Hypertension | Pregnancy | Animal models | Reproduction | Placenta | Fetal growth retardation | Preeclampsia | Blastocyst | Blood pressure | Female animals | Hemolytic anemia, elevated liver enzymes, and low platelet count | Trophoblast | 3-hydroxy-3-methyl-glutaryl-CoA | LOVASTATIN | ANGIOGENESIS | LENTIVIRUS | MULTIDISCIPLINARY SCIENCES | SOLUBLE ENDOGLIN | hemolytic anemia, elevated liver enzymes, and low platelet count | PREGNANCY | GENE-TRANSFER | FETAL | trophoblast | SIMVASTATIN | HYPERTENSION | EXPOSURE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Pre-Eclampsia - genetics | Humans | Pregnancy Proteins - genetics | Male | Pregnancy Proteins - metabolism | Pre-Eclampsia - prevention & control | HEK293 Cells | Female | Lentivirus - genetics | Pre-Eclampsia - metabolism | Disease Models, Animal | Vascular Endothelial Growth Factor Receptor-1 - genetics | Animals, Newborn | Pravastatin - pharmacology | Cell Line | Transduction, Genetic | Injections, Intraperitoneal | Mice, Transgenic | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Placenta - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Pravastatin - administration & dosage | Placenta Growth Factor | Mice | Development and progression | Models | Dosage and administration | Drug therapy | Pravastatin | Vascular endothelial growth factor | Health aspects | Biological Sciences
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 06/2018, Volume 501, Issue 2, pp. 605 - 606
Journal Article
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 09/2019, Volume 20, Issue 17, p. 4246
Preeclampsia, a systemic vascular disorder characterized by new-onset hypertension and proteinuria after 20 weeks of gestation, is the leading cause of...
arterial stiffness | soluble fms-like tyrosine kinase 1 | NORMAL-PREGNANCY | PULSE-WAVE VELOCITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | preeclampsia | endothelial dysfunction | CHEMISTRY, MULTIDISCIPLINARY | TYROSINE KINASE 1 | BLOOD-PRESSURE | placental growth factor | CIRCULATING ANGIOGENIC FACTORS | angiogenic imbalance | LOW-DOSE ASPIRIN | vascular endothelial growth factor | systemic vascular dysfunction | MOLECULAR-WEIGHT HEPARIN | NITRIC-OXIDE | INTRAUTERINE GROWTH RESTRICTION | 11-13 WEEKS GESTATION
arterial stiffness | soluble fms-like tyrosine kinase 1 | NORMAL-PREGNANCY | PULSE-WAVE VELOCITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | preeclampsia | endothelial dysfunction | CHEMISTRY, MULTIDISCIPLINARY | TYROSINE KINASE 1 | BLOOD-PRESSURE | placental growth factor | CIRCULATING ANGIOGENIC FACTORS | angiogenic imbalance | LOW-DOSE ASPIRIN | vascular endothelial growth factor | systemic vascular dysfunction | MOLECULAR-WEIGHT HEPARIN | NITRIC-OXIDE | INTRAUTERINE GROWTH RESTRICTION | 11-13 WEEKS GESTATION
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 08/2019, Volume 516, Issue 3, pp. 941 - 944
Recently, advanced maternal age (AMA) has been increasing due to late marriage and assisted reproductive technology. AMA is high-risk pregnancy associated with...
Mouse model | HDP | VEGF | Endothelin-1 | Advanced maternal age | BIOCHEMISTRY & MOLECULAR BIOLOGY | RISK | ADVERSE OUTCOMES | PREECLAMPSIA | ANGIOGENIC FACTORS | WOMEN | BIOPHYSICS | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | GROWTH-FACTOR | Hypertension | Pregnancy | Medical colleges | Endothelin | Endothelial growth factors | Pregnant women | Analysis | Obstetrics
Mouse model | HDP | VEGF | Endothelin-1 | Advanced maternal age | BIOCHEMISTRY & MOLECULAR BIOLOGY | RISK | ADVERSE OUTCOMES | PREECLAMPSIA | ANGIOGENIC FACTORS | WOMEN | BIOPHYSICS | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | GROWTH-FACTOR | Hypertension | Pregnancy | Medical colleges | Endothelin | Endothelial growth factors | Pregnant women | Analysis | Obstetrics
Journal Article
Scientific Reports, ISSN 2045-2322, 04/2016, Volume 6, Issue 1, p. 24853
Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFLT1) is an angiogenesis inhibitor that competes with angiogenic factors such as VEGF and...
FLT-1 GENE | FACTOR-A | INHIBITION | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | GENE-THERAPY | PREECLAMPSIA | DYSFUNCTION | HYPERTENSION | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Colorectal carcinoma | Cytology | Colorectal cancer | Cytotoxicity | Pre-eclampsia | Ovarian cancer | Angiogenesis | Transfection | Placenta | Rodents | Vascular endothelial growth factor | Apoptosis | Tumors
FLT-1 GENE | FACTOR-A | INHIBITION | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | GENE-THERAPY | PREECLAMPSIA | DYSFUNCTION | HYPERTENSION | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Colorectal carcinoma | Cytology | Colorectal cancer | Cytotoxicity | Pre-eclampsia | Ovarian cancer | Angiogenesis | Transfection | Placenta | Rodents | Vascular endothelial growth factor | Apoptosis | Tumors
Journal Article
Hypertension Research, ISSN 0916-9636, 01/2019, Volume 42, Issue 1, pp. 29 - 39
Recently, advanced maternal age (AMA) has increased in Western countries because of late marriage and advances in assisted reproductive technology. One major...
PATHOGENESIS | TYROSINE KINASE-1 | H2O2-INDUCED PREMATURE SENESCENCE | ATHEROSCLEROSIS | CELL SENESCENCE | RISK | PERIPHERAL VASCULAR DISEASE | ADVERSE OUTCOMES | PREECLAMPSIA | UTERINE PERFUSION-PRESSURE | FIBROBLASTS
PATHOGENESIS | TYROSINE KINASE-1 | H2O2-INDUCED PREMATURE SENESCENCE | ATHEROSCLEROSIS | CELL SENESCENCE | RISK | PERIPHERAL VASCULAR DISEASE | ADVERSE OUTCOMES | PREECLAMPSIA | UTERINE PERFUSION-PRESSURE | FIBROBLASTS
Journal Article
Journal of Obstetrics and Gynaecology Research, ISSN 1341-8076, 06/2018, Volume 44, Issue 6, pp. 1080 - 1086
Aim Previous studies have shown adverse obstetric outcomes of the laparoscopic resection of a rudimentary horn. Our study aimed to investigate the obstetric...
preterm birth | rudimentary horn | small for gestational age | vaginal delivery | unicornuate uterus | MANAGEMENT | MYOMECTOMY | BIRTH | OBSTETRICS & GYNECOLOGY | Hypertension | Care and treatment | Analysis | Patient outcomes | Laparoscopic surgery | Laparoscopy | Cesarean section | Uterus | Premature birth | Pregnancy complications | Data processing | Obstetrics | Gestational age
preterm birth | rudimentary horn | small for gestational age | vaginal delivery | unicornuate uterus | MANAGEMENT | MYOMECTOMY | BIRTH | OBSTETRICS & GYNECOLOGY | Hypertension | Care and treatment | Analysis | Patient outcomes | Laparoscopic surgery | Laparoscopy | Cesarean section | Uterus | Premature birth | Pregnancy complications | Data processing | Obstetrics | Gestational age
Journal Article
Journal of Obstetrics and Gynaecology Research, ISSN 1341-8076, 12/2016, Volume 42, Issue 12, pp. 1858 - 1863
Placenta percreta is a rare condition that presents a risk of massive intraoperative hemorrhage. To decrease maternal morbidity in such cases, conservative...
magnetic resonance imaging | placenta percreta | conservative management | placenta previa | Placenta percreta | Placenta previa | Magnetic resonance imaging | Conservative management | ACCRETA | OBSTETRICS & GYNECOLOGY | Placenta Accreta - surgery | Humans | Conservative Treatment | Gadolinium | Treatment Outcome | Gestational Age | Placenta Previa - surgery | Pregnancy | Magnetic Resonance Imaging | Placenta Accreta - diagnostic imaging | Contrast Media | Ultrasonography, Prenatal | Adult | Female | Investigations | Literature reviews | Placenta | Nuclear magnetic resonance--NMR | Hemorrhage | Morbidity
magnetic resonance imaging | placenta percreta | conservative management | placenta previa | Placenta percreta | Placenta previa | Magnetic resonance imaging | Conservative management | ACCRETA | OBSTETRICS & GYNECOLOGY | Placenta Accreta - surgery | Humans | Conservative Treatment | Gadolinium | Treatment Outcome | Gestational Age | Placenta Previa - surgery | Pregnancy | Magnetic Resonance Imaging | Placenta Accreta - diagnostic imaging | Contrast Media | Ultrasonography, Prenatal | Adult | Female | Investigations | Literature reviews | Placenta | Nuclear magnetic resonance--NMR | Hemorrhage | Morbidity
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 02/2018, Volume 496, Issue 4, pp. 1243 - 1249
Placenta previa is an abnormality in which the placenta covers the internal uterine os, and it can cause serious morbidity and mortality in both mother and...
Soluble fms-like tyrosine kinase-1 (sFLT-1) | Placental migration | Placenta previa | MIGRATION | WOMEN | BIOPHYSICS | ENDOGLIN | ABNORMAL PLACENTATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | PREECLAMPSIA | HYPOXIA | PREVIA | Placenta Previa - mortality | Species Specificity | Placentation | Humans | Middle Aged | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Organ Specificity | Mice, Inbred ICR | Placenta - metabolism | Pregnancy | Tissue Distribution | Animals | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Adult | Female | In Vitro Techniques
Soluble fms-like tyrosine kinase-1 (sFLT-1) | Placental migration | Placenta previa | MIGRATION | WOMEN | BIOPHYSICS | ENDOGLIN | ABNORMAL PLACENTATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | PREECLAMPSIA | HYPOXIA | PREVIA | Placenta Previa - mortality | Species Specificity | Placentation | Humans | Middle Aged | Vascular Endothelial Growth Factor Receptor-1 - metabolism | Organ Specificity | Mice, Inbred ICR | Placenta - metabolism | Pregnancy | Tissue Distribution | Animals | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Adult | Female | In Vitro Techniques
Journal Article
Placenta, ISSN 0143-4004, 11/2019, Volume 87, pp. 61 - 61
Journal Article
Placenta, ISSN 0143-4004, 11/2019, Volume 87, pp. 64 - 65
Journal Article
Placenta, ISSN 0143-4004, 11/2019, Volume 87, pp. 72 - 72
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2012, Volume 87, Issue 1, pp. 15 - 21
Of infants born to women with idiopathic thrombocytopenic purpura (ITP), about 10–15% have transient neonatal immune thrombocytopenic purpura (NITP). Of...
AUTOIMMUNE THROMBOCYTOPENIA | MANAGEMENT | THERAPY | PLATELET COUNTS | NEWBORN | MATERNAL CHARACTERISTICS | BORN | RISK | HEMATOLOGY | INTRACRANIAL HEMORRHAGE | PRENATAL-DIAGNOSIS | Purpura, Thrombocytopenic, Idiopathic - complications | Prognosis | Humans | Risk Factors | Pregnancy | Young Adult | Platelet Count | Thrombocytopenia, Neonatal Alloimmune - diagnosis | Thrombocytopenia, Neonatal Alloimmune - etiology | Adult | Female | Pregnancy Complications, Hematologic - diagnosis | Pregnancy Complications, Hematologic - etiology | Retrospective Studies | Infant, Newborn
AUTOIMMUNE THROMBOCYTOPENIA | MANAGEMENT | THERAPY | PLATELET COUNTS | NEWBORN | MATERNAL CHARACTERISTICS | BORN | RISK | HEMATOLOGY | INTRACRANIAL HEMORRHAGE | PRENATAL-DIAGNOSIS | Purpura, Thrombocytopenic, Idiopathic - complications | Prognosis | Humans | Risk Factors | Pregnancy | Young Adult | Platelet Count | Thrombocytopenia, Neonatal Alloimmune - diagnosis | Thrombocytopenia, Neonatal Alloimmune - etiology | Adult | Female | Pregnancy Complications, Hematologic - diagnosis | Pregnancy Complications, Hematologic - etiology | Retrospective Studies | Infant, Newborn
Journal Article
American Journal of Reproductive Immunology, ISSN 1046-7408, 11/2019, Volume 82, Issue 5, p. n/a
Problem Recent advances in lipid research have revealed that impairments in lipid mediator signaling can be involved in the pathoetiology of a variety of...
placenta | lysophosphatidic acid receptor | preeclampsia | human | OXIDATIVE STRESS | INCREASES | IMMUNOLOGY | LYSOPHOSPHOLIPASE-D | WOMEN | REPRODUCTIVE BIOLOGY | PROTEIN-COUPLED RECEPTOR | IMPLANTATION | ROLES | GROWTH | LPA | AUTOTAXIN | Immunohistochemistry | Pregnancy | Lysophosphatidic acid receptors | Placenta | Lysophosphatidic acid | Preeclampsia | Immunoblotting | Pre-eclampsia | Gene expression
placenta | lysophosphatidic acid receptor | preeclampsia | human | OXIDATIVE STRESS | INCREASES | IMMUNOLOGY | LYSOPHOSPHOLIPASE-D | WOMEN | REPRODUCTIVE BIOLOGY | PROTEIN-COUPLED RECEPTOR | IMPLANTATION | ROLES | GROWTH | LPA | AUTOTAXIN | Immunohistochemistry | Pregnancy | Lysophosphatidic acid receptors | Placenta | Lysophosphatidic acid | Preeclampsia | Immunoblotting | Pre-eclampsia | Gene expression
Journal Article
The Journal of Gene Medicine, ISSN 1099-498X, 11/2019
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 07/2019, Volume 9, Issue 1, pp. 10107 - 7
Hydatidiform moles are known to pose an extremely high risk of severe early-onset preeclampsia if left untreated. TNF superfamily cytokine, LIGHT has recently...
PROTEINURIA | ACTIVATION | HYPERTENSION | CONTRIBUTES | EXPRESSION | MULTIDISCIPLINARY SCIENCES | Serum levels | Hydatidiform mole | Tumor necrosis factor | Preeclampsia | Light | Pre-eclampsia | Enzyme-linked immunosorbent assay
PROTEINURIA | ACTIVATION | HYPERTENSION | CONTRIBUTES | EXPRESSION | MULTIDISCIPLINARY SCIENCES | Serum levels | Hydatidiform mole | Tumor necrosis factor | Preeclampsia | Light | Pre-eclampsia | Enzyme-linked immunosorbent assay
Journal Article
Journal of Obstetrics and Gynaecology Research, ISSN 1341-8076, 10/2018, Volume 44, Issue 10, pp. 1947 - 1955
Aim Ovarian tissue cryopreservation before cancer treatment is the only option to preserve fertility under some circumstances. However, tissue ischemia after...
gelatin hydrogel | ovarian tissue cryopreservation | angiogenesis | heterotopic xenograft | basic fibroblast growth factor | SURVIVAL | FERTILITY PRESERVATION | FACTOR BFGF | XENOTRANSPLANTATION | RABBIT MODEL | OBSTETRICS & GYNECOLOGY | INTERNAL THORACIC ARTERIES | PREPUBERTAL GIRLS | MICE | ENHANCED ANGIOGENESIS | FOLLICULOGENESIS | Biodegradation, Environmental | Hydrogels | Humans | Mice, Inbred C57BL | Fibroblast Growth Factor 2 - administration & dosage | Animals | Heterografts | Cryopreservation | Gelatin | Female | Ovary - drug effects | Mice | Delayed-Action Preparations | Neovascularization, Physiologic | Disease Models, Animal | Phosphates | Drugs | Drug delivery systems | Analysis | Fibroblast growth factors | Neovascularization | Vehicles | Cell proliferation | Fibroblast growth factor 2 | Fibroblast growth factor | Cell survival | Biodegradability | Immunodeficiency | Transplantation | Drug delivery | Biological activity | Endothelial cells | Vascularization | Angiogenesis | Ischemia | Fibrosis | Xenografts | Fibroblasts | Growth factors | Controlled release | Cancer
gelatin hydrogel | ovarian tissue cryopreservation | angiogenesis | heterotopic xenograft | basic fibroblast growth factor | SURVIVAL | FERTILITY PRESERVATION | FACTOR BFGF | XENOTRANSPLANTATION | RABBIT MODEL | OBSTETRICS & GYNECOLOGY | INTERNAL THORACIC ARTERIES | PREPUBERTAL GIRLS | MICE | ENHANCED ANGIOGENESIS | FOLLICULOGENESIS | Biodegradation, Environmental | Hydrogels | Humans | Mice, Inbred C57BL | Fibroblast Growth Factor 2 - administration & dosage | Animals | Heterografts | Cryopreservation | Gelatin | Female | Ovary - drug effects | Mice | Delayed-Action Preparations | Neovascularization, Physiologic | Disease Models, Animal | Phosphates | Drugs | Drug delivery systems | Analysis | Fibroblast growth factors | Neovascularization | Vehicles | Cell proliferation | Fibroblast growth factor 2 | Fibroblast growth factor | Cell survival | Biodegradability | Immunodeficiency | Transplantation | Drug delivery | Biological activity | Endothelial cells | Vascularization | Angiogenesis | Ischemia | Fibrosis | Xenografts | Fibroblasts | Growth factors | Controlled release | Cancer
Journal Article
Reproductive Medicine and Biology, ISSN 1445-5781, 07/2018, Volume 17, Issue 3, pp. 255 - 261
Purpose During the implantation period, the uterus goes through many complex, orchestrated changes, including alterations of the glycocalyx that are due to...
oxidation‐reduction potential | uterine receptivity | implantation | infertility | assisted reproductive technology treatment | oxidation-reduction potential
oxidation‐reduction potential | uterine receptivity | implantation | infertility | assisted reproductive technology treatment | oxidation-reduction potential
Journal Article